Sofinnova Ventures »

Tango Therapeutics shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.3M 395k 20.92

More positions owned by Sofinnova Ventures

Natera (NTRA)
iShares TR Russell 2000 Etf Put Option (IWM)
United Therapeutics Corporation Put Option (UTHR)
SPDR Series Trust State Street Spd Put Option (XBI)
Bristol Myers Squibb (BMY)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Vera Therapeutics Cl A (VERA)
AstraZeneca Ord (AZN)
Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Cogent Biosciences (COGT)
iShares TR Ishares Biotech Put Option (IBB)
Celcuity (CELC)
Ultragenyx Pharmaceutical (RARE)
Axsome Therapeutics Put Option (AXSM)
Rapport Therapeutics (RAPP)

View all positions for Sofinnova Ventures

Top funds holding Tango Therapeutics

Farallon Capital Management
Boxer Capital Management
Adage Capital Partners GP
TCG Crossover Management
BlackRock
Siren
Woodline Partners
Nextech Invest
Vanguard Group
Trv Gp Iv
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Deerfield Management Company
Paradigm Biocapital Advisors

View all funds holding Tango Therapeutics